1. Home
  2. NXRT vs ABCL Comparison

NXRT vs ABCL Comparison

Compare NXRT & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXRT
  • ABCL
  • Stock Information
  • Founded
  • NXRT 2014
  • ABCL 2012
  • Country
  • NXRT United States
  • ABCL Canada
  • Employees
  • NXRT N/A
  • ABCL N/A
  • Industry
  • NXRT Real Estate Investment Trusts
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXRT Real Estate
  • ABCL Health Care
  • Exchange
  • NXRT Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • NXRT 911.6M
  • ABCL 818.2M
  • IPO Year
  • NXRT N/A
  • ABCL 2020
  • Fundamental
  • Price
  • NXRT $36.49
  • ABCL $2.42
  • Analyst Decision
  • NXRT Buy
  • ABCL Buy
  • Analyst Count
  • NXRT 6
  • ABCL 3
  • Target Price
  • NXRT $46.33
  • ABCL $7.50
  • AVG Volume (30 Days)
  • NXRT 185.9K
  • ABCL 4.1M
  • Earning Date
  • NXRT 04-29-2025
  • ABCL 05-08-2025
  • Dividend Yield
  • NXRT 5.59%
  • ABCL N/A
  • EPS Growth
  • NXRT N/A
  • ABCL N/A
  • EPS
  • NXRT 0.04
  • ABCL N/A
  • Revenue
  • NXRT $259,873,000.00
  • ABCL $28,833,000.00
  • Revenue This Year
  • NXRT $0.06
  • ABCL N/A
  • Revenue Next Year
  • NXRT $5.96
  • ABCL $27.77
  • P/E Ratio
  • NXRT $842.80
  • ABCL N/A
  • Revenue Growth
  • NXRT N/A
  • ABCL N/A
  • 52 Week Low
  • NXRT $30.73
  • ABCL $1.89
  • 52 Week High
  • NXRT $48.37
  • ABCL $4.34
  • Technical
  • Relative Strength Index (RSI)
  • NXRT 46.60
  • ABCL 52.58
  • Support Level
  • NXRT $35.38
  • ABCL $1.89
  • Resistance Level
  • NXRT $36.21
  • ABCL $2.53
  • Average True Range (ATR)
  • NXRT 1.71
  • ABCL 0.19
  • MACD
  • NXRT 0.02
  • ABCL 0.05
  • Stochastic Oscillator
  • NXRT 56.22
  • ABCL 82.79

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: